Anne Bormann Kennedy

Insider Reports History

Location
Somerville, MA
Signature
/s/ Beth Hecht, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anne Bormann Kennedy:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. Director Common Stock 142,500 $1,010,937 $7.09 12 Dec 2025 Direct
XERIS PHARMACEUTICALS INC Director Stock Option (Right to Buy) 0 05 Oct 2021 Direct

Insider Reports Filed by Anne Bormann Kennedy

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XERS Xeris Biopharma Holdings, Inc. 12 Dec 2025 1 -$106,414 4 Director 15 Dec 2025, 17:24
XERS Xeris Biopharma Holdings, Inc. 04 Jun 2025 1 $0 4 Director 04 Jun 2025, 19:07
XERS Xeris Biopharma Holdings, Inc. 05 Jun 2024 1 $0 4 Director 05 Jun 2024, 16:19
XERS Xeris Biopharma Holdings, Inc. 07 Jun 2023 1 $0 4 Director 07 Jun 2023, 17:02
XERS Xeris Biopharma Holdings, Inc. 08 Jun 2022 2 +$31,500 4 Director 09 Jun 2022, 17:15
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 4 $0 4 Director 05 Oct 2021, 19:50
/report/000089924321039260-bormann-kennedy-barbara-jean-anne-2021-10-05 XERIS PHARMACEUTICALS INC 05 Oct 2021 4 $0 4 Director 05 Oct 2021, 17:38
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 0 $0 3 Director 05 Oct 2021, 17:20
/report/000134630221000058-bormann-kennedy-barbara-jean-anne-2021-06-08 XERIS PHARMACEUTICALS INC 08 Jun 2021 1 $0 4 Director 08 Jun 2021, 19:08